Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
This study has been completed.
Study NCT00001533   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: July 14, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia
Leukemia, T-Cell
Lymphocytosis
Neutropenia
Thrombocytopenia
Additional conditions recognized in this trial
Leukemia
Lymphoproliferative Disorders
More general conditions related to this trial
Agranulocytosis
Blood Platelet Disorders
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Leukemia, Lymphoid
Leukocyte Disorders
Leukocytosis
Leukopenia
Lymphatic Diseases
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
cyclosporine
Additional drug interventions recognized in this trial
Cyclosporins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services